Organization | Welsh Wound Innovation Centre Ltd

Welsh Wound Innovation Centre Ltd Report issue

Academic/Hospital Phase 2

Founded: Pontyclun United Kingdom (2014)

Organization Overview

First Clinical Trial

2019

NCT03865147

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2019

Timeline

NOW

Now

Alternative names

Welsh Wound Innovation Centre | Welsh Wound Innovation Centre Ltd

Active Ingredients

Drugs in Phase 2 Trials (7)

acetaminophen (tylenol) (1 trial)

bupivacaine (Exparel) (1 trial)

cetrimide (1 trial)

epinephrine (levophed) (1 trial)

ibuprofen (motrin) (1 trial)

lidocaine (xylocaine) (1 trial)

prilocaine (citanest) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Wounds and Injuries (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 1
# of Trial APIs: 7